Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ohnuma

Showing results (51-60 of 172) with videos related to

Pageof 18
Sort By:
Cancer Treatment Reports|March 1, 1983
Dialyzability of methyl-GAGB Jensen, R D Williams, T Ohnuma, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Clinical and laboratory reevalution of dichloromethotrexateB Fernbach, I Takahashi, T Ohnuma, et al.
British Journal of Cancer|September 1, 1988
Interactions of doxorubicin and cis-platin in squamous carcinoma cells in cultureN Kohno, T Ohnuma, M Kaneko, et al.
FEBS Letters|March 15, 1993
Cleavage of human MDR1 mRNA by a hammerhead ribozymeH Kobayashi, T Dorai, J F Holland, et al.
Cancer Research|January 15, 1988
Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in cultureY Kano, T Ohnuma, T Okano, et al.
European Journal of Cancer|March 1, 1979
Pharmacological and therapeutic efficacy of rubidazone in mice. Comparison with daunomycin and adriamycinT Ohnuma, F Elias, J F Holland, et al.
Biochemical Pharmacology|August 27, 1998
Vincristine saturation of cellular binding sites and its cytotoxic activity in human lymphoblastic leukemia cells: mechanism of inoculum effectH Kobayashi, Y Takemura, J F Holland, et al.
Journal of the National Cancer Institute|October 1, 1977
L-asparagine requirements of human T-lymphocytes and B-lymphocytes in cultureT Ohnuma, J F Holland, H Arkin, et al.
Molecular Pharmacology|September 1, 1994
Modulation of platelet-derived growth factor-beta mRNA expression and cell growth in a human mesothelioma cell line by a hammerhead ribozymeT Dorai, H Kobayashi, J F Holland, et al.
Cancer Research|March 1, 1994
Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDR1 (PGY1) ribozymeH Kobayashi, T Dorai, J F Holland, et al.
Pageof 18

Showing results (51-60 of 172) with videos related to

Sort By:
Pageof 18
Cancer Treatment Reports|March 1, 1983
Dialyzability of methyl-GAGB Jensen, R D Williams, T Ohnuma, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Clinical and laboratory reevalution of dichloromethotrexateB Fernbach, I Takahashi, T Ohnuma, et al.
British Journal of Cancer|September 1, 1988
Interactions of doxorubicin and cis-platin in squamous carcinoma cells in cultureN Kohno, T Ohnuma, M Kaneko, et al.
FEBS Letters|March 15, 1993
Cleavage of human MDR1 mRNA by a hammerhead ribozymeH Kobayashi, T Dorai, J F Holland, et al.
Cancer Research|January 15, 1988
Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in cultureY Kano, T Ohnuma, T Okano, et al.
European Journal of Cancer|March 1, 1979
Pharmacological and therapeutic efficacy of rubidazone in mice. Comparison with daunomycin and adriamycinT Ohnuma, F Elias, J F Holland, et al.
Biochemical Pharmacology|August 27, 1998
Vincristine saturation of cellular binding sites and its cytotoxic activity in human lymphoblastic leukemia cells: mechanism of inoculum effectH Kobayashi, Y Takemura, J F Holland, et al.
Journal of the National Cancer Institute|October 1, 1977
L-asparagine requirements of human T-lymphocytes and B-lymphocytes in cultureT Ohnuma, J F Holland, H Arkin, et al.
Molecular Pharmacology|September 1, 1994
Modulation of platelet-derived growth factor-beta mRNA expression and cell growth in a human mesothelioma cell line by a hammerhead ribozymeT Dorai, H Kobayashi, J F Holland, et al.
Cancer Research|March 1, 1994
Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDR1 (PGY1) ribozymeH Kobayashi, T Dorai, J F Holland, et al.
Pageof 18